{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:31:46Z","timestamp":1759332706251},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2005,12,20]],"date-time":"2005-12-20T00:00:00Z","timestamp":1135036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,12,20]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Human visceral leishmaniasis (VL), also known as kala azar (KA) in India, is a systemic progressive disease caused by Leishmania donovani. In VL, Th1 responses correlate with recovery from and resistance to disease and resolution of infection results in lifelong immunity against the disease. However, recent data suggest an important role for interleukin (IL)-10 in maintaining the resistant state. We evaluated whole cell extract (WE) and 11 antigenic fractions [F1\u2013F11, molecular weight (MW) range of 139\u201324\u00b72\u2003kDa] from L. donovani (2001 strain, a fresh field isolate from Bihar), for their ability to induce in vitro T cell proliferation and production of interferon (IFN)-\u03b3, interleukin (IL)-12, IL-10 and IL-4 by peripheral blood mononuclear cells (PBMCs) of exposed immune individuals (14 patients with history of VL, 10 household endemic contacts) and 20 non-endemic healthy controls. Twenty-one of 24 exposed individuals and no healthy controls showed proliferative response to WE. Whole-extract activated IFN-\u03b3, IL-12, IL-10 levels were higher in the exposed group than in controls; IL-4 was not detectable in any of the samples. Among 21 responders to WE, frequent proliferative responses were seen to fractions F1\u2013F4 (MW\u2003&amp;gt;\u200364\u00b72\u2003kDa) and none to fractions F5\u2013F11; fractions F1\u2013F11 stimulated comparable levels of IFN-\u03b3 and IL-12 while IL-10 levels were higher in response to F5\u2013F11 compared to F1\u2013F4. These data demonstrate the presence of immunostimulatory antigens in the high MW fractions of whole L. donovani antigen. However, these fractions do not stimulate a Th1 response and produce variable amounts of IFN-\u03b3 and the regulatory cytokine, IL-10. Hence, these high MW immunostimulatory fractions need to be evaluated in greater depth for their possible role as protective antigens.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2005.03000.x","type":"journal-article","created":{"date-parts":[[2005,12,22]],"date-time":"2005-12-22T13:12:46Z","timestamp":1135257166000},"page":"380-388","source":"Crossref","is-referenced-by-count":12,"title":["Identification of<i>Leishmania donovani<\/i>antigens stimulating cellular immune responses in exposed immune individuals"],"prefix":"10.1093","volume":"143","author":[{"given":"P","family":"Tripathi","sequence":"first","affiliation":[{"name":"Department of Immunology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Ray","sequence":"additional","affiliation":[{"name":"Department of Immunology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Sunder","sequence":"additional","affiliation":[{"name":"Department of Medicine, Banaras Hindu University, Varanasi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Dube","sequence":"additional","affiliation":[{"name":"Division of Parasitology, Central Drug Research Institute, Lucknow, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Naik","sequence":"additional","affiliation":[{"name":"Department of Immunology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,12,22]]},"reference":[{"key":"2022010522205054300_b1","first-page":"62","article-title":"Epidemiology of visceral leishmaniasis in India","volume":"12","author":"Bora","year":"1999","journal-title":"Natl Med J India"},{"key":"2022010522205054300_b2","first-page":"72","article-title":"Development of vaccines against leishmaniasis","volume":"76","author":"Modabber","year":"1990","journal-title":"Scand J Infect Dis"},{"key":"2022010522205054300_b3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0065-308X(08)60208-0","article-title":"Immunology of leishmaniasis","volume":"32","author":"Liewn","year":"1993","journal-title":"Adv Parasitol"},{"key":"2022010522205054300_b4","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nri933","article-title":"The immunology of susceptibility and resistance to Leishmania major in mice","volume":"2","author":"Sacks","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"2022010522205054300_b5","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/j.vaccine.2004.11.061","article-title":"Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes","volume":"23","author":"Lemesre","year":"2005","journal-title":"Vaccine"},{"key":"2022010522205054300_b6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0001-706X(03)00023-8","article-title":"Experimental canine leishmaniasis: evolution of infection following re-challenge with Leishmania infantum","volume":"87","author":"Gabriela","year":"2003","journal-title":"Acta Tropica"},{"key":"2022010522205054300_b7","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1016\/S0264-410X(01)00031-7","article-title":"Vaccination of Balb\/c mice against experimental visceral leishmaniasis with the GP36 glycoprotein antigen of Leishmania donovani","volume":"19","author":"De Souza","year":"2001","journal-title":"Vaccine"},{"key":"2022010522205054300_b8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.femsim.2004.05.008","article-title":"Vaccination with Leishmania soluble antigen and immunostimulatory oligodeoxynucleotides induces specific immunity and protection against Leishmania donovani infection","volume":"42","author":"Tewary","year":"2004","journal-title":"FEMS Immunol Med Microbiol"},{"key":"2022010522205054300_b9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0165-2478(98)00132-1","article-title":"T-cell response in human leishmaniasis","volume":"65","author":"Kharazmi","year":"1999","journal-title":"Immunol Lett"},{"key":"2022010522205054300_b10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2249.1995.tb03660.x","article-title":"Dichotomy of T cell response to leishmania antigens in patients suffering from cutaneous leishmaniasis: absence or scarcity of Th1 activity is associated with severe infections","volume":"100","author":"Gaafar","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"2022010522205054300_b11","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1172\/JCI116341","article-title":"Cytokine patterns in the pathogenesis of human leishmaniasis","volume":"91","author":"Pirmez","year":"1993","journal-title":"J Clin Invest"},{"key":"2022010522205054300_b12","doi-asserted-by":"crossref","first-page":"F53","DOI":"10.1084\/jem.194.10.f53","article-title":"Regulatory role of T cells producing both interferon-\u03b3 and interleukin-10 in persistent infection","volume":"194","author":"Trinchieri","year":"2001","journal-title":"J Exp Med"},{"key":"2022010522205054300_b13","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.4049\/jimmunol.170.4.1746","article-title":"The Leishmania mexicana cysteine protease, CPB2.8, induces potent Th2 responses","volume":"170","author":"Pollock","year":"2003","journal-title":"J Immunol"},{"key":"2022010522205054300_b14","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.4049\/jimmunol.172.6.3793","article-title":"Vaccination with phosphoglycan-deficient Leishmania major protects highly susceptible mice from virulent challenge without inducing a strong Th1 response","volume":"172","author":"Uzonna","year":"2004","journal-title":"J Immunol"},{"key":"2022010522205054300_b15","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1126\/science.7725103","article-title":"Expression cloning of a protective leishmania antigen","volume":"268","author":"Mougneau","year":"1995","journal-title":"Science"},{"key":"2022010522205054300_b16","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1128\/IAI.69.6.4103-4108.2001","article-title":"Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human disease","volume":"69","author":"Campos-Neto","year":"2001","journal-title":"Infect Immun"},{"key":"2022010522205054300_b17","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1126\/science.274.5286.421","article-title":"Resistance to Leishmania major induced by tolerance to a single antigen","volume":"274","author":"Julia","year":"1996","journal-title":"Science"},{"key":"2022010522205054300_b18","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.4049\/jimmunol.157.11.5034","article-title":"Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis","volume":"157","author":"Webb","year":"1996","journal-title":"J Immunol"},{"key":"2022010522205054300_b19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4269\/ajtmh.1992.46.123","article-title":"Leishmania chagasi antigens recognized in cured visceral leishmaniasis and asymptomatic infection","volume":"462","author":"White","year":"1992","journal-title":"Am J Trop Med Hyg"},{"key":"2022010522205054300_b20","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1128\/jcm.29.4.757-763.1991","article-title":"Immune reactivity to fractionated Leishmania aethiopica antigens during active human infection","volume":"29","author":"Laskay","year":"1991","journal-title":"J Clin Microbiol"},{"key":"2022010522205054300_b21","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1172\/JCI114093","article-title":"Profile of human T cell response to leishmanial antigens. Analysis by immunoblotting","volume":"83","author":"Melby","year":"1989","journal-title":"J Clin Invest"},{"key":"2022010522205054300_b22","doi-asserted-by":"crossref","first-page":"498","DOI":"10.4049\/jimmunol.166.1.498","article-title":"Identification and characterization of a T cell stimulating antigens from Leishmania by CD4 T cell expression cloning","volume":"166","author":"Probst","year":"2001","journal-title":"J Immunol"},{"key":"2022010522205054300_b23","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/infdis\/172.4.1055","article-title":"Identification of Leishmania chagasi antigens recognized by human lymphocytes","volume":"172","author":"Jeronimo","year":"1995","journal-title":"J Infect Dis"},{"key":"2022010522205054300_b24","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1172\/JCI114493","article-title":"In vitro responses to leishmania antigens by lymphocytes from patients with leishmaniasis or Chagas\u2019 disease","volume":"85","author":"Reed","year":"1990","journal-title":"J Clin Invest"},{"key":"2022010522205054300_b25","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2249.2005.02745.x","article-title":"Immunostimulatory cellular responses of cured leishmania infected patients and hamsters against integral membrane proteins and non-membranous soluble proteins of a recent clinical isolate of Leishmania donovani","volume":"140","author":"Garg","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"2022010522205054300_b26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0022-1759(87)90429-7","article-title":"A simple new method for using antigens separated by polyacrylamide gel electrophoresis to stimulate lymphocytes in vitro after converting bands cut from Western blots into antigen bearing particles","volume":"98","author":"Abou-Zeid","year":"1987","journal-title":"J Immunol Meth"},{"key":"2022010522205054300_b27","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.yexmp.2003.10.007","article-title":"Human S-antigen: peptide determinant recognition in uveitis patients","volume":"76","author":"Tripathi","year":"2004","journal-title":"Exp Mol Pathol"},{"key":"2022010522205054300_b28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0952-7915(06)80032-4","article-title":"Immunology of leishmaniasis","volume":"4","author":"Locksley","year":"1992","journal-title":"Curr Opin Immunol"},{"key":"2022010522205054300_b29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1365-2249.1999.00844.x","article-title":"Leishmanin skin test lymphoproliferative responses and cytokine production after symptomatic or asymptomatic Leishmania major infection in Tunisia","volume":"116","author":"Louzir","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"2022010522205054300_b30","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1590\/S0074-02761999000300015","article-title":"T cell response of asymptomatic Leishmania chagasi infected subjects to recombinant leishmania antigens","volume":"94","author":"Costa","year":"1999","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"2022010522205054300_b31","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1046\/j.1365-3083.2000.00724.x","article-title":"Distinct innate and acquired immune response to leishmania in putative susceptible and resistant human population endemically exposed to L. (Viannia) panamensis infection","volume":"51","author":"Bosque","year":"2000","journal-title":"Scand J Immunol"},{"key":"2022010522205054300_b32","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.4049\/jimmunol.152.12.5949","article-title":"Restoration of IFN-\u03b3 production and lymphocyte proliferation in visceral leishmaniasis","volume":"152","author":"Carvalho","year":"1994","journal-title":"J Immunol"},{"key":"2022010522205054300_b33","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.4049\/jimmunol.160.8.3949","article-title":"Induction of a Th1 immune response and simultaneous lack of activation of a Th2 response is required for generation of immunity to leishmaniasis","volume":"160","author":"Sj\u00f6lander","year":"1998","journal-title":"J Immunol"},{"key":"2022010522205054300_b34","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1084\/jem.177.6.1797","article-title":"Resolution of cutaneous leishmaniasis: IL-12 initiates a protective T helper type 1 immune response","volume":"177","author":"Sypek","year":"1993","journal-title":"J Exp Med"},{"key":"2022010522205054300_b35","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.4049\/jimmunol.154.9.4623","article-title":"Interleukin-12 enhances Th1 type immune response in human Leishmania donovani infection","volume":"154","author":"Ghalib","year":"1995","journal-title":"J Immunol"},{"key":"2022010522205054300_b36","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/infdis\/173.6.1515","article-title":"Interleukin-12 restores interferon-\u03b3 production and cytotoxic responses in visceral leishmaniasis","volume":"173","author":"Bacellar","year":"1996","journal-title":"J Infect Dis"},{"key":"2022010522205054300_b37","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.4049\/jimmunol.147.9.3149","article-title":"IFN-\u03b3 modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis","volume":"147","author":"Scott","year":"1991","journal-title":"J Immunol"},{"key":"2022010522205054300_b38","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0090-1229(90)90038-R","article-title":"Determinants of the immune response in visceral leishmaniasis: evidence for predominance of endogenous interleukin-4 over interferon-\u03b3 production","volume":"57","author":"Zwingenberger","year":"1990","journal-title":"Clin Immunol Immunopathol"},{"key":"2022010522205054300_b39","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1172\/JCI116570","article-title":"Interleukin-10 production correlates with pathology in human Leishmania donovani infection","volume":"92","author":"Ghalib","year":"1993","journal-title":"J Clin Invest"},{"key":"2022010522205054300_b40","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.4049\/jimmunol.166.2.1141","article-title":"The role of IL-10 in promoting disease progression in leishmaniasis","volume":"166","author":"Kane","year":"2001","journal-title":"J Immunol"},{"key":"2022010522205054300_b41","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1046\/j.1365-2249.1999.00918.x","article-title":"Leishmania-specific T cells expressing interferon-gamma (IFN-gamma) and IL-10 upon activation are expanded in individuals cured of visceral leishmaniasis","volume":"116","author":"Kemp","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"2022010522205054300_b42","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1084\/jem.194.10.1497","article-title":"The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure","volume":"194","author":"Belkaid","year":"2001","journal-title":"J Exp Med"},{"key":"2022010522205054300_b43","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1046\/j.1365-2249.1998.00468.x","article-title":"High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of post-kala azar dermal leishmaniasis","volume":"111","author":"Gasim","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"2022010522205054300_b44","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1016\/S0264-410X(02)00302-X","article-title":"Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in Mpl adjuvant","volume":"20","author":"Skeiky","year":"2002","journal-title":"Vaccine"},{"key":"2022010522205054300_b45","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1128\/IAI.69.1.245-251.2001","article-title":"Vervet monkeys vaccinated with killed Leishmania major parasites and interleukin-12 develop a type 1 immune response but are not protected against challenge infection","volume":"69","author":"Gicheru","year":"2001","journal-title":"Infect Immun"},{"key":"2022010522205054300_b46","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1128\/IAI.68.2.630-636.2000","article-title":"A novel Leishmania infantum recombinant antigen which elicits interleukin-10 production by peripheral blood mononuclear cell of patients with visceral leishmaniasis","volume":"68","author":"Suffia","year":"2000","journal-title":"Infect Immun"},{"key":"2022010522205054300_b47","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nature01152","article-title":"CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity","volume":"420","author":"Belkaid","year":"2002","journal-title":"Nature"},{"key":"2022010522205054300_b48","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1084\/jem.20040298","article-title":"Role for CD4+CD25+ regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity","volume":"200","author":"Mendez","year":"2004","journal-title":"J Exp Med"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2005.03000.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/143\/2\/380\/42075700\/j.1365-2249.2005.03000.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/143\/2\/380\/42075700\/j.1365-2249.2005.03000.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T22:02:23Z","timestamp":1706824943000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/143\/2\/380\/6457921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12,20]]},"references-count":48,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2005,12,22]]},"published-print":{"date-parts":[[2005,12,20]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2005.03000.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,2]]},"published":{"date-parts":[[2005,12,20]]}}}